Effectiveness of Shakuyaku-kanzo-to in neuroleptic-induced hyperprolactinemia: A preliminary report

Kazuo Yamada, Shigenobu Kanba, Takaaki Murata, Motoko Fukuzawa, Bokusou Terashi, Gohei Yagi, Masahiro Asai

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

We investigated the efficacy of Shakuyaku-kanzo-to (TJ-68) in neuroleptic-induced hyperprolactinemia in 11 treated schizophrenic patients. The mean plasma prolactin level decreased significantly from 28.9 ± 14.5 ng/mL at baseline to 22.0 ± 15.2 ng/mL at 4 weeks. Potassium levels did not change significantly. Neither the exacerbation of psychosis nor other adverse effects occurred.

Original languageEnglish
Pages (from-to)341-342
Number of pages2
JournalPsychiatry and clinical neurosciences
Volume50
Issue number6
DOIs
Publication statusPublished - Jan 1 1996

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)
  • Neurology
  • Clinical Neurology
  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Effectiveness of Shakuyaku-kanzo-to in neuroleptic-induced hyperprolactinemia: A preliminary report'. Together they form a unique fingerprint.

  • Cite this